Sildenafil can be a potent and selective inhibitor of cGMP-unique phosphodiesterase variety 5 (PDE5), which is chargeable for degradation of cGMP from the corpus cavernosum. The molecular structure of sildenafil is similar to that of cGMP and functions like a competitive binding agent of PDE5 from the corpus cavernosum, leading to much more cGMP an